Overview

Hepatitis B Virus (HBV) Viral Suppression by Entecavir in Adefovir Partial Responders

Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
We propose a largely retrospective study with short-term prospective follow-up in a subgroup of patients who have not yet been treated with 48 weeks of entecavir following partial response to adefovir. The aim of the study is to describe sequential virologic response to adefovir and entecavir.
Details
Lead Sponsor:
Pacific Health Foundation
Collaborator:
Bristol-Myers Squibb
Treatments:
Adefovir
Adefovir dipivoxil
Entecavir